Pharma & Biotech

Natera Inc. finds itself at a pivotal moment as it prepares to release third-quarter 2025 financial results after market close...

Kura Oncology faces a defining period with two significant catalysts on the immediate horizon. The biotechnology firm prepares to disclose...

Eli Lilly has delivered a stunning quarterly performance that shattered market expectations, driven by two revolutionary medications transforming diabetes and...

Today marks a pivotal moment for Liquidia Corporation as the biotechnology firm prepares to release its third-quarter 2025 financial performance....

The medical technology firm Baxter is navigating its most severe crisis in recent memory. A confluence of operational hurdles and...

The animal health company Zoetis finds itself at a critical juncture as it prepares to announce its third-quarter financial results...

Pharmaceutical giant Bristol-Myers Squibb finds itself navigating complex challenges as its stock continues to face downward pressure despite demonstrating operational...

After a period of disappointing results, Danaher Corporation is demonstrating renewed strength. The life sciences giant not only delivered an...

The biotech sector is watching closely as Anavex Life Sciences continues to advance its lead therapeutic candidate, Blarcamesine, for early...

Moderna shares experienced a dramatic upswing following reports of potential acquisition talks or a major strategic partnership, breaking a prolonged...